Annual securities reports (有価証券報告書) filed on EDINET — management narrative only (statistics tables, financial-statement notes, director remuneration and cross-shareholding disclosure are excluded). TSE corporate-governance reports and TDnet are separate documents and are not read here.
Stella Pharma Corporation 4888
| Cost of capital | no mention | matched by rule |
|---|---|---|
| PBR | no mention | matched by rule |
| Metric | no metric named | matched by rule |
| Target | no numeric target | matched by rule |
| Payout | policy language, no number 「また、計画どおりに当期純利益を計上できない場合には、繰越利益剰余金がプラスとなる時期も遅延し、配当による株主還元の実施時期が遅れる可能性があります」BusinessRisksTextBlock | matched by rule |
For desks: your watchlist through these questions, kept current each filing season. Custom, from $999+.
Reply with your names